Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy-Reference-Cited by-同舟云学术

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

Published:2019-11-25 Issue:3 Volume:52 Page:202-206
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Vizcarra Pilar¹^ORCID,Blanco José L.²,Montejano Rocío³,Negredo Eugenia⁴,Espinosa Nuria⁵,Casado José L.¹^ORCID,

Affiliation:

1. Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain;

2. Department of Infectious Diseases, Hospital Clínic, Barcelona, Spain;

3. Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain;

4. HIV Unit & Lluita Contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain;

5. Department of Infectious Diseases, Microbiology and Preventive Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2019.1694696

Reference17 articles.

1. Dual Raltegravir–Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

2. Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy

3. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

4. Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance;eLife;2023-03-15

2. Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective;AIDS;2021-12-15

3. Transmitted drug resistance among HIV-1 drug-naïve patients in Greece;International Journal of Infectious Diseases;2021-04